Anticipated $1.38 EPS for Medtronic plc (MDT) on May, 24

May 16, 2018 - By Sonya McDaniel

Medtronic plc (NYSE:MDT) Corporate Logo
Big Money Sentiment decreased to 1.02 in 2017 Q4. It has change of 0.10, from 2017Q3’s 1.12. The ratio worsened due to Medtronic plc positioning: 65 sold and 427 reduced. 111 funds took stakes and 393 increased stakes. Investors holded 1.07 billion in 2017Q3 but now own 1.04 billion shares or 2.98% less.
First Commonwealth Financial Corporation Pa invested in 0.25% or 2,952 shs. Goldman Sachs Group Inc Inc reported 0.18% of its capital in Medtronic plc (NYSE:MDT). Moreover, Roundview Ltd Company has 0.15% invested in Medtronic plc (NYSE:MDT). Winch Advisory Services Ltd Limited Liability Company holds 218 shs. Telemus Cap Limited Liability Corporation owns 8,993 shs. Checchi Capital Advisers Ltd Liability Com invested in 0.1% or 9,485 shs. South Dakota Investment Council has invested 1.11% in Medtronic plc (NYSE:MDT). Butensky & Cohen Fincl Security owns 20,154 shs for 1.35% of their capital. Walter And Keenan Consulting Company Mi Adv accumulated 0.75% or 22,222 shs. Intact Invest Inc invested 0.04% in Medtronic plc (NYSE:MDT). Vaughan Nelson Investment Mngmt Lp has invested 0.43% of its capital in Medtronic plc (NYSE:MDT). Advisors Capital Management Ltd Co reported 0.87% stake. Smith Moore & Communication invested in 0.18% or 8,150 shs. Colony Grp Ltd stated it has 0.78% of its capital in Medtronic plc (NYSE:MDT). The Louisiana-based Louisiana State Employees Retirement has invested 0.3% in Medtronic plc (NYSE:MDT).

Investors wait Medtronic plc (NYSE:MDT)’s quarterly earnings on May, 24 before the open., as reported by RTT. Analysts forecast $1.38 EPS. That’s $0.05 up or 3.76 % from 2017’s earnings of $1.33. This could reach $1.87 billion profit for MDT assuming the current $1.38 EPS will become reality. Wall Street now forecasts 17.95 % EPS growth despite Medtronic plc previous quarter’s EPS of $1.17. The stock increased 1.39% or $1.17 during the last trading session, reaching $85.54.Medtronic plc has volume of 3.49M shares. Since May 16, 2017 MDT has declined 3.54% and is downtrending. MDT underperformed by 15.09% the S&P 500.

Medtronic plc (NYSE:MDT) Ratings Coverage

Total analysts of 11 have positions in Medtronic (NYSE:MDT) as follows: 9 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 82%. Since November 17, 2017 according to StockzIntelligence Inc Medtronic has 13 analyst reports. On Friday, November 17 the firm has “Buy” rating given by SunTrust. On Wednesday, February 21 the firm has “Buy” rating given by Needham. The stock rating was upgraded by Bank of America to “Buy” on Tuesday, January 2. In Tuesday, November 21 report Jefferies maintained the stock with “Buy” rating. On Friday, April 27 the company was initiated by Piper Jaffray. On Tuesday, November 21 the stock has “Buy” rating by Needham. The stock rating was maintained by Morgan Stanley with “Equal-Weight” on Monday, February 5. The company rating was upgraded by Argus Research on Tuesday, December 12. On Wednesday, November 22 Stifel Nicolaus maintained the shares of MDT in report with “Hold” rating. On Thursday, February 22 the firm has “Buy” rating given by Citigroup.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide.The firm is worth $115.94 billion. The company's Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software.The P/E ratio is 41.85. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

For more Medtronic plc (NYSE:MDT) news released recently go to: Streetinsider.com, Globenewswire.com, Globenewswire.com, Seekingalpha.com or Globenewswire.com. The titles are as follows: “Medtronic (MDT) Highlights New Analysis Showing Cardiac Resynchronization Therapy Feature Associated with …” released on May 15, 2018, “Medtronic Announces New Paid Family Care Leave Benefits” on May 01, 2018, “Detailed Research: Economic Perspectives on Medtronic, NVIDIA, NutriSystem, AmTrust Financial Services, Kratos …” with a publish date: May 16, 2018, “Medtronic Should Focus On Aggressive Deleveraging” and the last “Mike Weinstein to Join Medtronic as Senior Vice President of Strategy” with publication date: May 07, 2018.

Medtronic plc (NYSE:MDT) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: